New Survey Measures the Pulse of RBM & ICH-E6 (R2) Adoption in the Clinical Trials Industry
May 23rd 2019Abby Abraham, Vice President, Data Analytics, and RBM for OmniComm Systems, writes about a new survey that highlights gaps in the conversation surrounding the industry’s adoption and implementation of risk-based approaches to monitoring.